Fluorescence Polarization Immunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·TDX CYCLOSPORINE AND METABOLITES SERUME ASSAY

Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·COBAS INTEGRA CYCLOSPORINE

Fluorescence Polarization Immunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·TDX CYCLOSPORINE AND METABOLITES SERUME ASSAY

Radioimmunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·1YCLO-TRAC SP WHOLE BLOOD & SERUM/PLASMA ASSAYS

Enzyme Immunoassay, Cannabinoids

FDA Pre-Market Approval

FDA Class 2 ·DR. BROWN'S HOME DRUG TESTING KIT

Enzyme Immunoassay, Tracrolimus

FDA Pre-Market Approval

FDA Class 2 ·IMX TACROLIMUS II

Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·EMIT 2000 CYCLOSPORINE SPECIFIC ASSAY

Fluorescence Polarization Immunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·TDX/TDXFLX CYCLOSPORINE AND METABOLITES WHOLE BLOOD/MONOCLONAL WHOLE BLOOD

Fluorescence Polarization Immunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·TDX CYCLOSPORINE AND METABOLITES SERUME ASSAY

Fluorescence Polarization Immunoassay For Cyclosporine

FDA Pre-Market Approval

FDA Class 2 ·TD CYCLOSPORINE AND METABOLITES SERUM ASSAY

VISTA DIGITAL OPTHALMOSCOPE

FDA 510(k)

FDA Class 2 ·Ophthalmic

Gas Control Unit, Cardiopulmonary Bypass

FDA classification

FDA Class 2 ·Gas Control Unit, Cardiopulmonary Bypass

Kidney Perfusion Kit

FDA classification

FDA Class 2 ·Kidney Perfusion Kit

Parenteral Administration Kit

FDA classification

FDA Class 2 ·Parenteral Administration Kit

Colposcope (And Colpomicroscope), Exempt

FDA classification

FDA Class 2 ·Colposcope (And Colpomicroscope), Exempt

PHENOBARBITAL FLEX REAGENT CARTRIDGE

FDA 510(k)

FDA Class 2 ·Clinical Toxicology

Wisdiag Multi-Drug Urine Test Cup, Wisdiag Multi-Drug Urine Test Cup Rx

FDA 510(k)

FDA Class 2 ·Clinical Toxicology

SYNCHRON SYSTEMS METHAQUALONE REAGENT

FDA 510(k)

FDA Class 2 ·Clinical Toxicology

T3 RIA (PEG) DIAGNOSTIC KIT

FDA 510(k)

FDA Class 2 ·Clinical Chemistry

LABELING CHANGE CANNABINOIDS DOUBLE ANTI. IN URINE

FDA 510(k)

FDA Class 2 ·Clinical Toxicology